Melanomas with concordant loss of multiple melanocytic differentiation proteins: Immune escape that may be overcome by targeting unique or undefined antigens

Cancer Immunology Immunotherapy

Volumn 48, Issue 12, 2000, Pages 661-672

  Slingluff Jr , Craig L ^a   Colella, Teresa A ^b   Thompson, Lee ^a   Graham, D David ^a   Skipper, Jonathan C A ^b,d   Caldwell, Jennifer ^b   Brinckerhoff, Larry ^a   Kittlesen, David J ^a   Deacon, Donna H ^a   Oei, Correen ^c   Harthun, Nancy L ^a   Huczko, Eric L ^b   Hunt, Donald F ^a,b   Darrow, Tim L ^c   Engelhard, Victor H ^b  

^a UNIVERSITY OF VIRGINIA   (United States)

^b UNIVERSITY OF VIRGINIA   (United States)

^c DUKE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^d UNIVERSITY OF OXFORD   (United Kingdom)

Author keywords

Antigens; Cytotoxic T lymphocytes; Human; Immunotherapy; Melanoma

Indexed keywords

ALLOANTIGEN; EPITOPE; HLA A ANTIGEN; MONOPHENOL MONOOXYGENASE; TUMOR VACCINE;

ANTIGEN EXPRESSION; ANTIGEN PRESENTATION; ARTICLE; CYTOLYSIS; CYTOTOXIC T LYMPHOCYTE; HUMAN; HUMAN CELL; IMMUNOAFFINITY CHROMATOGRAPHY; IMMUNOTHERAPY; MAJOR HISTOCOMPATIBILITY COMPLEX; MELANOMA; PRIORITY JOURNAL;

EID: 0034100812     PISSN: 03407004     EISSN: None     Source Type: Journal    
DOI: 10.1007/s002620050015     Document Type: Article

References (32)

1. Adema GJ, DeBoer AJ, Vogel AM, Loenen WA, Figdor CG (1994) Molecular characterization of the melanocyte lineage-specific antigen gp100. J Biol Chem 269:20126
2. Bakker AB, Marland HG, deBoer AJ, Huijbens RJF, Danen EHJ, Adema GJ, Figdor CG (1995) Generation of antimelanoma cytotoxic T lymphocytes from healthy donors after presentation of melanoma-associated antigen-derived epitopes by dendritic cells in vitro. Cancer Res 55:5330
3. Bakker AB, Schreurs MW, Tafazzul G, de Boer AJ, Kawakami Y, Adema GJ, Figdor CG (1995) Identification of a novel peptide derived from the melanocyte-specific gp100 antigen as the dominant epitope recognized by an HLA-A2.1-restricted anti-melanoma CTL line. Int J Cancer 62:97
4. Bernhard EJ, Le AT, Barbosa JA, Lacy E, Engelhard VH (1988) Cytotoxic T lymphocytes from HLA-A2 transgenic mice specific for HLA-A2 expressed on human cells. J Exp Med 168:1157
5. Boel P, Wildmann C, Sensi ML, Brasseur R, Renauld JC, Coulie P, Boon T, Bruggen P van der (1995) BAGE: a new gene encoding an antigen recognized on human melanomas by cytolytic T lymphocytes. Immunity 2:167
6. Bouchard B, Fuller BB, Vijayasaradhi S, Houghton AN (1989) Induction of pigmentation in mouse fibroblasts by expression of human tyrosinase cDNA. J Exp Med 169:2029
7. Brasseur F, Marchand M, Vanwijck R, Herin M, Lethé B, Chomez P, Boon T (1992) Human gene MAGE-1, which codes for a tumor rejection antigen, is expressed by some breast tumors. Int J Cancer 52:839
8. Chen YT, Stockert E, Tsang S, Coplan KA, Old LJ (1995) Immunophenotyping of melanomas for tyrosinase: implications for vaccine development. Proc Natl Acad Sci USA 92:8125
9. Chen YT, Gure AO, Tsang S, Stockert E, Jager E, Knuth A, Old LJ (1998) Identification of multiple cancer/testis antigens by allogeneic antibody screening of a melanoma cell line library. Proc Natl Acad Sci USA 95:6919
10. Cox AL, Skipper J, Chen Y, Henderson RA, Darrow TL, Shabanowitz J, Engelhard VH, Hunt DF, Slingluff CL Jr (1994) Identification of a peptide recognized by five melanoma-specific human cytotoxic T cell lines. Science 264:716
11. Crowley NJ, Darrow TL, Quinn-Allen MA, Seigler HF (1991) MHC-restricted recognition of autologous melanoma by tumor-specific cytotoxic T cells evidence for restriction by a dominant HLA-A allele. J Immunol 146:1692
12. Darrow TL, Slingluff CL Jr, Seigler HF (1989) The role of HLA class I antigens in recognition of melanoma cells by tumor-specific cytotoxic T lymphocytes. Evidence for shared tumor antigens. J Immunol 142:3329
13. DeVries TJ, Fourkour A, Wobbes T, Verkroost G, Ruiter DJ, Muijen GNP van (1997) Heterogeneous expression of immunotherapy candidate proteins gp100, MART-1, and tyrosinase in human melanoma cell lines and in human melanocytic lesions. Cancer Res 57:3223
14. Ha oncogene. Int J Cancer 66:557
15. Engelhard VH, Benjamin C (1982) Isolation and characterization of monoclonal mouse cytotoxic T lymphocytes with specificity for HLA-A,B or -DR alloantigens. J Immunol 129:2621
16. Gaugler B, Van den Eynde B, Van der Bruggen P, Romero P, Gatorio JJ, De Plaen E, Lethé B, Brasseur F, Boon T (1994) Human gene MAGE-3 codes for an antigen recognized on a melanoma by autologous cytolytic T lymphocytes. J Exp Med 179:921
17. Hay R, Caputo J, Chen TR, Macy M, McClintock P, Reid Y (1992) American Type Culture Collection catalogue of cell lines and hybridomas, 7th edn. ATCC, Rockville, Md
18. Henderson RA, Cox AL, Sakaguchi K, Appella E, Shabanowitz J, Hunt DF, Engelhard VH (1993) Direct identification of an endogenous peptide recognized by multiple HLA-A2.1 specific cytotoxic T-cells. Proc Natl Acad Sci USA 90:10275
19. Kawakami Y, Eliyahu S, Sakaguchi K, Robbins PF, Rivoltini L, Yannelli JR, Appella E, Rosenberg SA (1994) Identification of the immunodominant peptides of the MART-1 human melanoma antigen recognized by the majority of HLA-A2-restricted tumor infiltrating lymphocytes. J Exp Med 180:347
20. Kawakami Y, Eliyahu S, Jennings C, Sakaguchi K, Kang X, Southwood S, Robbins PF, Sette A, Appella E, Rosenberg SA (1995) Recognition of multiple epitopes in the human melanoma antigen gp100 by tumor-infiltrating T lymphocytes associated with in vivo tumor regression. J Immunol 154:3961
21. Kittlesen DJ, Thompson LW, Gulden PH, Skipper JCA, Colella TA, Shabanowitz JA, Hunt DF, Engelhard VH, Slingluff CL Jr. (1998) Human melanoma patients recognize an HLA-A1-restricted CTL epitope from tyrosinase containing two cysteine residues: implications for tumor vaccine development. J Immunol 160:2099
22. Mosse CA, Meadows L, Luckey CJ, Kittlesen DJ, Huczko EL, Slingluff CL, Shabanowitz J, Hunt DF, Engelhard VH. (1998) The class I antigen-processing pathway for the membrane protein tyrosinase involves translation in the endoplasmic reticulum and processing in the cytosol. J Exp Med 187:37
23. Nair SK, Boczkowski D, Morse M, Cumming RI, Lyerly HK, Gilboa E (1998) Induction of primary carcinoembryonic antigen (CEA)-specific cytotoxic T lymphocytes in vitro using human dendritic cells transfected with RNA. Nat Biotechnol 16:364
24. Restifo NP, Kawakami Y, Marincola F, Shamamian P, Taggarse A, Esquivel F, Rosenberg SA (1993) Molecular mechanisms used by tumors to escape immune recognition: immunogenetherapy and the cell biology of major histocompatibility complex class I. J Immunother 14:182
25. Robbins P F, El-Camil M, Li YF, Topalian S, Rivoltini L, Sakaguchi K, Apella E, Kawakimi Y, Rosenberg S (1995) Cloning of a new gene encoding an antigen recognized by melanoma-specific HAL-24-restricted tumor-infiltrating lymphocytes. J Immunol 154:594
26. Russo C, Ng A-K, Pellegrino MA, Ferrone S (1983) The monoclonal antibody CR11.351 discriminates HLA-A2 variants identified by T-cells. Immunogenetics 18:23
27. Salter RD, Howell DN, Cresswell P (1985) Genes regulating HLA class I antigen expression in T-B lymphoblast hybrids. Immunogenetics 21:235
28. Skipper JCA, Hendrickson RC, Gulden PH, Brichard V, VanPel A, Chen Y, Shabanowitz J, Wolfel T, Slingluff CL Jr, Boon T, Hunt DF, Engelhard VH. (1996) An HLA-A2 restricted tyrosinase antigen on melanoma cells results from post-translational modification. J Exp Med 183:527
29. Skipper JCA, Gulden PH, Hendrickson RC, Harthun N, Caldwell JA, Shabanowitz J, Engelhard VH, Hunt DF, Slingluff CL jr (1999) Mass-spectrometric evaluation of HLA-A*0201-associated peptides identifies dominant naturally-processed forms of CTL epitopes from MART-1 and gp100. Int J Cancer (in press)
30. Slingluff CL Jr (1996) Tumor antigens and tumor vaccines: peptides as immunogens. Semin Surg Oncol 12:446
31. Slingluff CL Jr, Cox AL, Henderson RA, Hunt DF, Engelhard VH (1993) Recognition of human melanoma cells by HLA-A2.1-restricted cytotoxic T lymphocytes is mediated by at least six shared peptide epitopes. J Immunol 150:2955
32. Van den Eynde B, Peeters O, DeBacker O, Gaugler B, Lucan S, Boon T (1995) A new family of genes coding for an antigen recognized by autologous cytolytic lymphocytes on a human melanoma. J Exp Med 182:689